![Brian Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Wong
Director/Board Member at
Plexium, Inc.
Profile
Brian Russell Wong is currently Director at Plexium, Inc. since 2022.
Formerly, Dr. Wong was President, Chief Executive Officer & Director at Rapt Therapeutics, Inc. from 2019 to 2026.
Dr. Wong was Director-Research at F.
Hoffmann-La Roche Ltd. from 2005 to 2009.
Dr. Wong was Associate Director at Rigel Pharmaceuticals, Inc. Dr. Wong was Senior VP-Research & Head-Immuno Oncology at Five Prime Therapeutics, Inc. in 2015.
Dr. Wong was Venture Partner at The Column Group LLC.
Dr. Wong completed undergraduate studies at Oberlin College and earned doctorates from The Rockefeller University and Weill Cornell Medical College.
Brian Wong active positions
| Companies | Position | Start |
|---|---|---|
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Director/Board Member | 2022-07-12 |
Former positions of Brian Wong
| Companies | Position | End |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Chief Executive Officer | 2026-03-02 |
| FIVE PRIME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2015-08-29 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Tech/Sci/R&D Officer | 2008-12-31 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Private Equity Investor | - |
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Brian Wong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Oberlin College
 Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Plexium, Inc.
Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
- Stock Market
- Insiders
- Brian Wong
